Selective matrix metalloproteinase inhibition influences LV geometry and myocardial structure in developing congestive heart failure

被引:0
|
作者
O'Neill, TP
King, MK
Coker, ML
Goldberg, AT
Morrison, AE
Holder, JR
Gunasinghe, HR
Mukherjee, R
Wendt, KA
Zile, MR
Spinale, FG
机构
[1] Procter & Gamble Co, Mason, OH USA
[2] Med Univ S Carolina, Charleston, SC 29425 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1429
引用
收藏
页码:292 / 292
页数:1
相关论文
共 50 条
  • [1] Selective matrix metalloproteinase inhibition influences LV function and geometry with developing congestive heart failure
    King, MK
    Coker, ML
    Goldberg, AT
    Morrison, AE
    McElmurray, JH
    Gunasinghe, HR
    Mukherjee, R
    Wendt, KA
    O'Neill, TP
    Zile, MR
    Spinale, FG
    [J]. CIRCULATION, 2000, 102 (18) : 452 - 452
  • [2] Selective matrix metalloproteinase inhibition influences regional myocardial geometry and reduces LV dilation following myocardial infarction
    Mukherjee, R
    Brinsa, TA
    Thornton, JL
    Yarbrough, WM
    Sample, JA
    Dowdy, KB
    O'Neill, TP
    Escobar, GP
    Spinale, FG
    [J]. CIRCULATION, 2002, 106 (19) : 266 - 266
  • [3] Selective matrix metalloproteinase inhibition with developing heart failure - Effects on left ventricular function and structure
    King, MK
    Coker, ML
    Goldberg, A
    McElmurray, JH
    Gunasinghe, HR
    Mukherjee, R
    Zile, MR
    O'Neill, TP
    Spinale, FG
    [J]. CIRCULATION RESEARCH, 2003, 92 (02) : 177 - 185
  • [4] Myocardial matrix metalloproteinase activity and abundance with congestive heart failure
    Coker, ML
    Thomas, CV
    Clair, MJ
    Hendrick, JW
    Krombach, RS
    Galis, Z
    Spinale, FG
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1998, 274 (05): : H1516 - H1523
  • [5] Matrix metalloproteinase inhibition with congestive heart failure improves left ventricular geometry and pump function
    Spinale, FG
    Krombach, RS
    Coker, ML
    Mukherjee, R
    Houck, WV
    Clair, MJ
    Kribbs, SB
    Hebbar, L
    Peterson, JT
    [J]. CIRCULATION, 1997, 96 (08) : 2915 - 2915
  • [6] Matrix metalloproteinase 2 is expressed in the heart of patients with congestive heart failure
    Burger, P
    Bernheim, A
    Linka, A
    Kiowski, W
    Rickli, H
    Brunner-La Rocca, HP
    [J]. EUROPEAN HEART JOURNAL, 2004, 25 : 77 - 77
  • [7] Combined angiotensin converting enzyme and matrix metalloproteinase inhibition with developing heart failure: Effects on left ventricular function and geometry
    Spinale, FG
    McElmurray, JH
    Mukherjee, R
    New, BR
    Sampson, AC
    King, MK
    Hendrick, JW
    Patterson, TM
    Peterson, JT
    Zile, MR
    [J]. CIRCULATION, 1999, 100 (18) : 647 - 647
  • [8] Matrix metalloproteinase inhibition attenuates LV remodeling after myocardial infarction
    Delyani, JA
    Casadas, V
    Campion, J
    Yu, Y
    Clawitter, J
    Becker, D
    Villamil, C
    DeCrescenzo, G
    Vaitkus, P
    Heron, MI
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2001, 33 (06) : A26 - A26
  • [9] Matrix metalloproteinase inhibition and the prevention of heart failure
    Lee, RT
    [J]. TRENDS IN CARDIOVASCULAR MEDICINE, 2001, 11 (05) : 202 - 205
  • [10] Angiotensin-converting enzyme and matrix metalloproteinase inhibition with developing heart failure: Comparative effects on left ventricular function and geometry
    McElmurray, JH
    Mukherjee, R
    New, RB
    Sampson, AC
    King, MK
    Hendrick, JW
    Goldberg, A
    Peterson, TJ
    Hallak, H
    Zile, MR
    Spinale, FG
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1999, 291 (02): : 799 - 811